Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000114099 | SCV000578530 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Color Diagnostics, |
RCV000581482 | SCV000689193 | likely benign | Hereditary cancer-predisposing syndrome | 2017-08-09 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000114099 | SCV001139260 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001500034 | SCV001704811 | likely benign | Hereditary breast ovarian cancer syndrome | 2021-10-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000581482 | SCV002532025 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-01 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV000581482 | SCV004005518 | likely benign | Hereditary cancer-predisposing syndrome | 2023-05-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breast Cancer Information Core |
RCV000114099 | SCV000147622 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2007-01-12 | no assertion criteria provided | clinical testing |